Zuellig Pharma Launches Lilly's Innovative Obesity and Diabetes Medicine in Thailand
Mounjaro® (tirzepatide) will be available in the market from the end of May 2025
BANGKOK, THAILAND - Media OutReach Newswire - 27 May 2025 - Zuellig Pharma, a leading healthcare solutions company in Asia, has announced that Mounjaro ® (tirzepatide), the innovative obesity and diabetes medicine developed by Eli Lilly and Company, will be launched in Thailand at the end of May 2025. Zuellig Pharma holds the marketing authorization for Mounjaro ® (tirzepatide) in Thailand, having been granted the distribution and promotion rights for the medicine by Eli Lilly and Company this year.
Mounjaro ® (tirzepatide) is a once-weekly prescription-only medicine indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise; as monotherapy when metformin is considered inappropriate due to intolerance or contraindications, in addition to other medicinal products for the treatment of diabetes; and as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial Body Mass Index (BMI) of ≥30 kg/m 2 (obesity) or ≥27 kg/m2 to < 30 kg/m 2 (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease, prediabetes, or type 2 diabetes mellitus).
The availability of Mounjaro ® (tirzepatide) is a significant advancement in the treatment of both obesity and type 2 diabetes, offering a single medication that can address both conditions through an easy-to-use prefilled pen. Mounjaro ® KwikPen ® (tirzepatide injection) is available in 2.5 mg, 5 mg, 7.5 mg and 10 mg, and gives healthcare providers the ability to personalize treatment plans better to meet individual patient needs.
Obesity is a critical public health concern in Thailand that affects 48% of the total population. 2 The Ministry of Public Health classifies obesity as a Non-Communicable Disease (NCD) due to its strong link to rising rates for chronic illnesses, particularly type 2 diabetes. In 2024, the Department of Disease Control reported that 1 in 10 Thai individuals – a total of 6.5 million people – suffer from type 2 diabetes, impacting their physical, mental, and social well-being. 2
People with diabetes face significant challenges in managing their blood sugar and preventing complications such as cardiovascular disease, chronic kidney disease, diabetic retinopathy, and diabetic foot ulcers, which can lead to severe infections and potential amputation. 3
"Obesity and diabetes have gained prominence as significant health challenges in Thailand, and we are excited to accelerate the availability of Mounjaro ® (tirzepatide) to patients in the region. With our deep understanding of the local regulatory landscape, as well as our proven track record of delivering innovative healthcare solutions in unmet disease areas, we are well placed to enhance the availability of the medicine in the market. This represents a significant step forward in our commitment to making healthcare more accessible, particularly in the chronic metabolic disease market," said Rehan Saghir, Executive Vice President of Zuellig Pharma's Commercialization division.
References:
Mounjaro. Prescribing Information. Eli Lilly Asia, Inc.
Division of Non-communicable Disease, Department of Disease Control, Ministry of Public Health)
Yang, T., Qi, F., Guo, F. et al. An update on chronic complications of diabetes mellitus: from molecular mechanisms to therapeutic strategies with a focus on metabolic memory. Mol Med 30, 71 (2024). https://doi.org/10.1186/s10020-024-00824-9
Hashtag: #ZuelligPharma #EliLillyandCompany #Diabetes #Obesity #Healthcare #Pharmaceuticals
https://www.zuelligpharma.com/
https://www.linkedin.com/company/zuellig-pharma
The issuer is solely responsible for the content of this announcement.
About Zuellig Pharma
Zuellig Pharma is a leading healthcare solutions company in Asia, and our purpose is to make healthcare more accessible to the communities we serve. We provide world-class distribution, digital and commercial services to support the growing healthcare needs in this region. The company was started a hundred years ago and has grown to become a multibillion-dollar business covering 17 markets with over 12,000 employees. Our people serve more than 200,000 medical facilities and work with over 450 clients, including the top 20 pharmaceutical companies in the world.
For more information, visit: https://www.zuelligpharma.com/
Zuellig Pharma
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
6 hours ago
- Zawya
KFSHRC Command Center atthe core of digital transformation and care excellence
King Faisal Specialist Hospital & Research Centre (KFSHRC) has advanced healthcare efficiency through its Capacity Command Center, a strategic pillar in the hospital's digital transformation journey. The Center has significantly optimized hospital-wide performance while delivering more responsive, patient-centered care. Established to modernize operations and elevate care, the Center provides real-time visibility across the patient journey—from admission to discharge—powered by a locally developed color-coded alert system that flags bottlenecks and enables timely intervention. This has improved operational efficiency and patient experience by streamlining admissions, discharges, and transfers, resulting in faster recovery, better resource use, and smoother clinical handovers. Building on this foundation, the Center leverages AI and big data to forecast patient volumes, identify pressure points, and guide precise resource allocation. These capabilities are reinforced by ongoing technical reporting, data mining, and performance reviews that translate insights into continuous institutional improvement. These innovations have led to a 14% reduction in average length of stay (ALOS) and a 19% drop in emergency department congestion, boosting patient recovery, bed availability, and patient safety. In parallel, overall hospital activity grew, with new patient admissions increasing by 10.3% to 46,476 in 2024, reflecting enhanced throughput and capacity management. Central to KFSHRC's transformation agenda, the Command Center exemplifies how AI and real-time analytics enable predictive, evidence-based decisions, advancing its mission to deliver high-quality, specialized care through a scalable intelligent healthcare model. It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 15th globally in the list of the world's top 250 Academic Medical Centers for the third consecutive year and recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, it was included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine. For more information, visit or contact our media team at mediacoverage@
Zawya
a day ago
- Zawya
Merck Foundation Officially Appoints the Maldives First Lady as the Ambassador of 'More Than a Mother' to Build Healthcare Capacity, Break Infertility Stigma and Stop Gender-Based Violence (GBV)
Merck Foundation ( the philanthropic arm of Merck KGaA Germany underscored their long-term commitment to build healthcare capacity and break infertility stigma in Maldives during their high-level meeting with H.E. Mrs. SAJIDHA MOHAMED, The First Lady of the Republic of Maldives, held at the Official Residence of the President. The discussion led by Prof. Dr. Frank Stangenberg Haverkamp, Chairman of Merck Foundation BOT and Senator, Dr. Rasha Kelej, CEO of Merck Foundation. Senator Dr. Rasha Kelej expressed, 'It was an honor to meet my dear sister H.E. Mrs. SAJIDHA MOHAMED, The First Lady of the Republic of Maldives, and officially appointing her to be the Ambassador of 'Merck Foundation More Than a Mother'. During our meeting we discussed our joint programs and underscored our commitment towards building healthcare capacity and transforming patient care landscape by providing scholarships for local doctors. We also discussed about addressing critical social and health issues in the country including breaking the infertility stigma, stopping gender-based violence, women empowerment, and diabetes and hypertension awareness.' H.E. Mrs. SAJIDHA MOHAMED, The First Lady of the Republic of Maldives and Ambassador of 'Merck Foundation More Than a Mother' expressed, 'It is a pleasure to welcome and meet Merck Foundation Chairman and CEO to our country. We discussed our joint programs. I am happy to share that we have already started providing scholarships for our local doctors in Fertility and Embryology training. These are two very critical specialties for our country. We also plan to enroll our doctors in other specialties, further underscoring our partnership with the Merck Foundation to enhance healthcare capacity in the Maldives.' Prof. Dr. Frank Stangenberg Haverkamp, Chairman of Merck Foundation BOT shared, 'Our aim is to improve the overall health and wellbeing of people by building healthcare capacity across Africa, Asia and other developing countries. We are strongly committed to transforming patientcare landscape through our scholarships program. Till today, we have provided more than 2270 scholarships for young doctors from 52 countries in 44 critical and underserved specialties.' During their visit to the Maldives, the Chairman and CEO of Merck Foundation also met with Hon. Mr. Abdulla Nazim Ibrahim, Minister of Health, where they discussed scaling up the scholarship programs in alignment with the country's healthcare needs. Through their Community Awareness Programs, Merck Foundation is also closely working with The First Lady of Maldives to address a wide range of critical social issues like breaking infertility stigma, stopping gender-based violence and women empowerment, and important health issues including promoting the importance of healthy lifestyle, and diabetes and hypertension awareness. Merck Foundation will be soon conducting their Health Media Training together with The First Lady of Maldives for the Maldivian journalists, to emphasize on the important role that media plays to influence society to create a cultural shift and be the voice of the voiceless. The training program will be addressed by prominent Medical and Media experts. Moreover, Merck Foundation in partnership with The First Lady of Maldives has also launched their 8 important Merck Foundation Awards for Maldivian Media, Musicians&Singers, Fashion Designers, Filmmakers, and students&new potential talents in these fields. 'I invite the young talents from the Maldives to share their entries with us,' added Senator Dr. Kelej. Details of the Awards: Merck Foundation Media Recognition Awards 'More Than a Mother' 2025, in partnership with The First Lady of Maldives: Media representatives and media students are invited to showcase their work to raise awareness about one or more of the following social issues: Breaking Infertility Stigma and Women Empowerment. Submission deadline: 30 th September 2025. Merck Foundation Fashion Awards 'More Than a Mother' 2025, in partnership with The First Lady of Maldives: All Fashion Students and Designers are invited to create and share designs to deliver strong and influential messages to raise awareness about one or more of the following social issues: Breaking Infertility Stigma and Women Empowerment. Submission deadline: 30 th September 2025. Merck Foundation Film Awards 'More Than a Mother' 2025, in partnership with The First Lady of Maldives: All Filmmakers, Students of Film Making Training Institutions, or Young Talents of Africa are invited to create and share a long or short FILMS, either drama, documentary, or docudrama to deliver strong and influential messages to address one or more of the following social issues: Breaking Infertility Stigma and Women Empowerment. Submission deadline: 30 th September 2025. Merck Foundation Song Awards 'More Than a Mother' 2025, in partnership with The First Lady of Maldives: All Singers and Musical Artists are invited to create and share a SONG with the aim to address one or more of the following social issues: Breaking Infertility Stigma and Women Empowerment. Submission deadline: 30 th September 2025. Merck Foundation Media Recognition Awards 'Diabetes&Hypertension' 2025, in partnership with The First Lady of Maldives: Media representatives are invited to showcase their work through strong and influential messages to promote a healthy lifestyle and raise awareness about the prevention and early detection of Diabetes and Hypertension. Submission deadline: 30 th October 2025. Merck Foundation Fashion Awards 'Diabetes&Hypertension' 2025, in partnership with The First Lady of Maldives: All Fashion Students and Designers are invited to create and share designs to deliver strong and influential messages to promote a healthy lifestyle and raise awareness about the prevention and early detection of Diabetes and Hypertension. Submission deadline: 30 th October 2025. Merck Foundation Film Awards 'Diabetes&Hypertension' 2025, in partnership with The First Lady of Maldives: All Filmmakers, Students of Film Making Training Institutions, or Young Talents of Africa are invited to create and share a long or short FILMS, either drama, documentary, or docudrama to deliver strong and influential messages to promote a healthy lifestyle raise awareness about prevention and early detection of Diabetes and Hypertension. Submission deadline: 30 th October 2025. Merck Foundation Song Awards 'Diabetes&Hypertension' 2025, in partnership with The First Lady of Maldives: All Singers and Musical Artists are invited to create and share a SONG with the aim to promote a healthy lifestyle and raise awareness about the prevention and early detection of Diabetes and Hypertension. Submission deadline: 30 th October 2025. Entries for the above awards can be submitted to us at: submit@ Distributed by APO Group on behalf of Merck Foundation. Join the conversation on our social media platforms below and let your voice be heard! Facebook: X: YouTube: Instagram: Threads: Flickr: Website: Download Merck Foundation App: About Merck Foundation: The Merck Foundation, established in 2017, is the philanthropic arm of Merck KGaA Germany, aims to improve the health and wellbeing of people and advance their lives through science and technology. Our efforts are primarily focused on improving access to quality&equitable healthcare solutions in underserved communities, building healthcare&scientific research capacity, empowering girls in education and empowering people in STEM (Science, Technology, Engineering, and Mathematics) with a special focus on women and youth. All Merck Foundation press releases are distributed by e-mail at the same time they become available on the Merck Foundation Website. Please visit to read more. Follow the social media of Merck Foundation: Facebook ( X ( Instagram ( YouTube ( Threads ( and Flickr ( The Merck Foundation is dedicated to improving social and health outcomes for communities in need. While it collaborates with various partners, including governments to achieve its humanitarian goals, the foundation remains strictly neutral in political matters. It does not engage in or support any political activities, elections, or regimes, focusing solely on its mission to elevate humanity and enhance well-being while maintaining a strict non-political stance in all of its endeavors.
Zawya
a day ago
- Zawya
Liberia: Ambassador Yin Chengwu Attends Handover Ceremony of Cardiology Department Project Under Paired Hospital Cooperation Mechanism
On June 3, Chinese Ambassador to Liberia Yin Chengwu attended the handover ceremony of the Cardiology Department project under the China-Liberia Paired Hospital Cooperation Mechanism. Also present were Liberian Health Minister Hon. Dr. Louise M. Kpoto, JFK Medical Center Chief Executive Officer Dr. Linda Birch, representatives from Heilongjiang Provincial Hospital, members of the 17th Chinese Medical Team to Liberia, and representatives from JFK Medical Center, totaling about 100 attendees. Minister Dr. Louise Kpoto and CEO Dr. Linda Birch expressed gratitude to the Chinese government for its long-term and strong support to Liberia's health sector. They stated that this project, as Liberia's first dedicated cardiology diagnosis and treatment department, would surely provide higher quality medical services to the people. Ambassador Yin pointed out that the Cardiology Department project is a powerful testament to the friendship between the two peoples, a concrete manifestation of China's policy towards Africa characterized by "sincerity, real results, amity and good faith", and a positive outcome of implementing the consensus reached by the leaders of the two countries at the Forum on China-Africa Cooperation (FOCAC) Beijing Summit. China, ambassador Yin affirmed, will continue to support the development of Liberia's health sector and promote Liberia's ARREST Agenda for Inclusive Development. Distributed by APO Group on behalf of Embassy of the People's Republic of China in the Republic of Liberia.
